|
Exempt Reporting Adviser
2B(3)- PF>150mn
|
|
| Private Fund GAV* | 0 |
| SMA’s | No |
| Private Funds | 0 1 |
| Stock Ticker | Stock Name | $ Position | % Position | $ Change | # Change |
|---|---|---|---|---|---|
| Stck Ticker252828108 | Stock NameDIANTHUS THERAPEUTICS INC | $ Position$184,747,355 | % Position42.00% | $ Change113.00% | # Change0.00% |
| Stck Ticker687604108 | Stock NameORUKA THERAPEUTICS INC | $ Position$52,020,606 | % Position12.00% | $ Change160.00% | # Change15.00% |
| Stck Ticker008064206 | Stock NameJADE BIOSCIENCES INC | $ Position$34,177,275 | % Position8.00% | $ Change58.00% | # Change0.00% |
| Stck Ticker46489V302 | Stock NamePERSPECTIVE THERAPEUTICS INC | $ Position$23,594,996 | % Position5.00% | $ Change167.00% | # Change88.00% |
| Stck Ticker29337E102 | Stock NameENLIVEN THERAPEUTICS INC | $ Position$16,492,000 | % Position4.00% | $ Change663.00% | # Change185.00% |
| Stck Ticker21077P108 | Stock NameCONTEXT THERAPEUTICS INC | $ Position$11,795,910 | % Position3.00% | $ Change46.00% | # Change-9.00% |
| Stck Ticker01021M104 | Stock NameAKTIS ONCOLOGY INC | $ Position$8,785,613 | % Position2.00% | $ Change | # Change |
| Stck Ticker697947109 | Stock NamePALVELLA THERAPEUTICS INC NE | $ Position$8,982,400 | % Position2.00% | $ Change345.00% | # Change263.00% |
| Stck Ticker759916109 | Stock NameREPLIGEN CORP | $ Position$9,204,518 | % Position2.00% | $ Change12.00% | # Change55.00% |
| Stck TickerG5960L103 | Stock NameMEDTRONIC PLC | $ Position$8,097,000 | % Position2.00% | $ Change-22.00% | # Change-7.00% |